All too often, big business wins out over the interests of the little guy or vice versa. However, the FDA approval of AMAG Pharmaceutical Inc’s Feraheme, an anemia medicine taking by injection, has proven to be beneficial to both parties. Shares of AMAG, a relatively small business, are up 5 percent, while anemia sufferers now have a new, more convenient drug available.
 
Feraheme has specifically been approved for adults as part of an iron replacement treatment for those afflicted with kidney disease. According to the company, chronic kidney disease suffers at every level of severity will have what is effectively a …read more

Having the U.S. Food and Drug Administration raid your pharmaceutical company and seize over thirty types of drugs seems like genuine cause for concern, but Caraco Pharmaceutical Laboratories Ltd. has expressed optimism instead. According to the generic drug producer, the third-party drugs that the government did not seize will generate enough profit for the company to stay afloat.
 
The FDA initiated the raid because it found that Caraco had been putting drugs with a variety of defects on the market. Although the company makes several popular medications and consumers may not even be aware if the medicine they take was made …read more